Molekule Financial Statements From 2010 to 2024

MKULDelisted Stock   2.25  0.15  7.14%   
Molekule financial statements provide useful quarterly and yearly information to potential Molekule Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Molekule financial statements helps investors assess Molekule's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Molekule's valuation are summarized below:
Molekule Group does not presently have any fundamental ratios for analysis.
Check Molekule financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Molekule's main balance sheet or income statement drivers, such as , as well as many indicators such as . Molekule financial statements analysis is a perfect complement when working with Molekule Valuation or Volatility modules.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Molekule Group Company Return On Asset Analysis

Molekule's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Molekule Return On Asset

    
  -0.25  
Most of Molekule's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molekule Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Molekule Group has a Return On Asset of -0.2518. This is 50.63% lower than that of the Machinery sector and 91.13% lower than that of the Industrials industry. The return on asset for all United States stocks is 79.86% higher than that of the company.

Molekule Group Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Molekule's current stock value. Our valuation model uses many indicators to compare Molekule value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Molekule competition to find correlations between indicators driving Molekule's intrinsic value. More Info.
Molekule Group is regarded fourth in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Molekule by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

About Molekule Financial Statements

Molekule investors utilize fundamental indicators, such as revenue or net income, to predict how Molekule Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Molekule Stock

If you are still planning to invest in Molekule Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molekule's history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon